Key result
Chitosan scaffolds restore infarcted myocardium function by improving electrical conductivity and angiogenesis.
Why the study?
Pharmaceutical and surgical treatments for necrotic myocardial tissue repair have adverse effects, prompting evaluation of biopolymer-based scaffolds as safer regenerative alternatives.
Do chitosan-based scaffolds improve myocardial tissue regeneration in models of myocardial infarction?
Systematic Review (n=75)
Do chitosan-based scaffolds improve myocardial tissue regeneration in models of myocardial infarction?
Chitosan-based scaffolds represent a promising, biocompatible approach for myocardial tissue engineering and regeneration following myocardial infarction.
Supports chitosan scaffold development for MI repair; extends preclinical tissue engineering data but leaves clinical translation open.
Cardiovascular diseases (CVD), such as myocardial infarction (MI), constitute one of the world's leading causes of annual deaths. This cardiomyopathy generates a tissue scar with poor anatomical properties and cell necrosis that can lead to heart failure. Necrotic tissue repair is required through pharmaceutical or surgical treatments to avoid such loss, which has associated adverse collateral effects. However, to recover the infarcted myocardial tissue, biopolymer-based scaffolds are used as safer alternative treatments with fewer side effects due to their biocompatibility, chemical adaptability and biodegradability. For this reason, a systematic review of the literature from the last five years on the production and application of chitosan scaffolds for the reconstructive engineering of myocardial tissue was carried out. Seventy-five records were included for review using the "preferred reporting items for systematic reviews and meta-analyses" data collection strategy. It was observed that the chitosan scaffolds have a remarkable capacity for restoring the essential functions of the heart through the mimicry of its physiological environment and with a controlled porosity that allows for the exchange of nutrients, the improvement of the electrical conductivity and the stimulation of cell differentiation of the stem cells. In addition, the chitosan scaffolds can significantly improve angiogenesis in the infarcted tissue by stimulating the production of the glycoprotein receptors of the vascular endothelial growth factor (VEGF) family. Therefore, the possible mechanisms of action of the chitosan scaffolds on cardiomyocytes and stem cells were analyzed. For all the advantages observed, it is considered that the treatment of MI with the chitosan scaffolds is promising, showing multiple advantages within the regenerative therapies of CVD.
No takes yet. Share an insight, caveat, or question.
Acosta et al. (2023) conducted a systematic review in Myocardial Infarction (n=75). Chitosan-based scaffolds was evaluated on Regenerative capacity of myocardial tissue. Chitosan-based scaffolds demonstrate a remarkable capacity for restoring essential heart functions by mimicking the physiological environment, improving electrical conductivity, and stimulating angiogenesis in infarcted myocardial tissue.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: